Our data in this report demonstrated that, FLLL32, a novel STAT3 inhibitor, efficiently inhibited STAT3 phosphorylation, STAT3 DNA binding activity, which resulted the induction of apoptosis in human colorectal cancer cell lines. This evidence concerns the gene STAT3 and colorectal cancer.